Linda N. Oshiro

Linda N. Oshiro serves as a Contract Specialist responsible for managing the full lifecycle of complex procurements within the federal healthcare and medical technology sector. She ensures compliance with the Federal Acquisition Regulation (FAR) and oversees solicitation development, source selection, contract award, and post-award administration for high-value medical equipment and diagnostic products. Her work directly supports mission-critical procurement objectives by securing reliable, high-quality medical supplies and devices essential to public health infrastructure. Oshiro typically handles competitive sealed bidding and negotiated acquisitions under FAR Part 15, with a focus on technical specifications for precision medical instruments and diagnostic systems. While specific contractor names are not available, Oshiro maintains a broad network of manufacturers and suppliers specializing in medical device production, including firms engaged in surgical instrumentation, in-vitro diagnostics, and electromedical apparatus manufacturing. Her contracting approach emphasizes vendor performance, quality assurance, and supply chain resilience, fostering long-term partnerships with vendors capable of meeting stringent regulatory and technical requirements under FDA and ISO standards. Oshiro’s procurement patterns reflect a strong preference for open competition, with 85% of awards issued without set-asides. However, she consistently supports small business participation, allocating 12.6% of awards to Total Small Business Set-Asides and 2.4% to Service-Disabled Veteran-Owned Small Business (SDVOSB) concerns. Her approach aligns with agency socioeconomic goals, balancing competitive efficiency with meaningful opportunities for qualified small businesses under FAR Part 19. Her primary procurement focus centers on NAICS 339112 (Surgical and Medical Instrument Manufacturing) and 339113 (Surgical Appliance and Supplies Manufacturing), accounting for nearly 70% of her portfolio. She also regularly acquires in-vitro diagnostic substances, pharmaceutical preparations, and electromedical devices, demonstrating deep technical familiarity with FDA-regulated medical products and the manufacturing standards governing their production and distribution.